Bill Cassidy, MD; Sunjay Letchuman, BBA
JAMA. 2023;330(13):1221-1222. doi:10.1001/jama.2023.16686
This Viewpoint discusses the lack of coordination of care that individuals who are eligible for both Medicare and Medicaid services face.
Sarah M. E. Gabriele, LLM, MBE; William B. Feldman, MD, DPhil, MPH
JAMA. 2023;330(13):1223-1224. doi:10.1001/jama.2023.17208
This Viewpoint discusses how limited-supply agreements (introduction of generic products in reduced volumes) might thwart efforts to negotiate lower prices on prescription drugs in the US.
Sarah H. Gordon, PhD; Megan B. Cole, PhD; Nicole Huberfeld, JD
JAMA. 2023;330(13):1225-1226. doi:10.1001/jama.2023.15811
This Viewpoint discusses the Georgia Pathways to Coverage program, which is the first state program that partially expands Medicaid eligibility to low-income adults with work requirements.
Patrick N. O’Mahen, PhD; Laura A. Petersen, MD, MPH
JAMA. 2023;330(13):1227-1228. doi:10.1001/jama.2023.17700
This Viewpoint discusses the reasons why Medicaid has not been expanded in all US states and explains how expansion might finally be achieved in the 10 holdout states.
S. Sean Tu, JD, PhD; Rebecca Tushnet, JD
JAMA. 2023;330(13):1229-1230. doi:10.1001/jama.2023.17974
This Viewpoint looks at the lawsuits brought by pharmaceutical companies to challenge the Inflation Reduction Act of 2022, in particular claims under the First Amendment’s protection of free speech.